HI
RGNX icon

Harbour Investments’s Regenxbio RGNX Stock Holding History

Harbour Investments’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11K Hold
93
– – ﹤0.01% 4190
2026
Q1 		$779 Hold
93
– – ﹤0.01% 4163
2025
Q4 		$1.34K Buy
+93
New +$1.16K ﹤0.01% 3397

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Harbour Investments's RGNX Position: Q2 2026 in Review

Harbour Investments held its Regenxbio (RGNX) position steady in Q2 2026 at 93 shares worth $1.11K. The position accounts for ﹤0.01% of the portfolio, ranked #4190.

Harbour Investments first reported a position in RGNX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.34K in Q4 2025. 164 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Harbour Investments held 93 shares of Regenxbio worth $1.11K as of Q2 2026.
  • Harbour Investments left its Regenxbio share count unchanged in Q2 2026.
  • Regenxbio made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4190 holding.
  • Harbour Investments first reported a position in Regenxbio in Q4 2025 and has held it in 3 quarters since.
  • Harbour Investments's Regenxbio position peaked at $1.34K in Q4 2025.
  • 164 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.